Hubei Jumpcan Pharmaceutical Co Ltd
SSE:600566
Wall Street
Price Targets
Price Targets Summary
Hubei Jumpcan Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Hubei Jumpcan Pharmaceutical Co Ltd is 32.19 CNY with a low forecast of 31.88 CNY and a high forecast of 33.14 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Hubei Jumpcan Pharmaceutical Co Ltd's stock price target?
Price Target
32.19
CNY
According to Wall Street analysts, the average 1-year price target for Hubei Jumpcan Pharmaceutical Co Ltd is 32.19 CNY with a low forecast of 31.88 CNY and a high forecast of 33.14 CNY.
What is Hubei Jumpcan Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
-2%
For the last 13 years the compound annual growth rate for Hubei Jumpcan Pharmaceutical Co Ltd's revenue is 31%. The projected CAGR for the next 3 years is -2%.
What is Hubei Jumpcan Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
-4%
For the last 13 years the compound annual growth rate for Hubei Jumpcan Pharmaceutical Co Ltd's operating income is 46%. The projected CAGR for the next 3 years is -4%.
What is Hubei Jumpcan Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
-6%
For the last 13 years the compound annual growth rate for Hubei Jumpcan Pharmaceutical Co Ltd's net income is 56%. The projected CAGR for the next 3 years is -6%.
